Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Susan, Realegeno"'
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 1 (2024)
ABSTRACT This study evaluated the performance of the PyloPlus Urea Breath Test (UBT) System, a Food and Drug Administration (FDA)-approved assay for diagnosis of Helicobacter pylori infection in adult patients, using samples from 111 pediatric patien
Externí odkaz:
https://doaj.org/article/d2c7bc3afab74c98b8d58ea6d95d074b
Autor:
Susan Realegeno, Sara Hash, Charlene Wong, Roland Liu, Jovan Shepherd, Robert T. Schooley, David A. Lipson, Frederick Fung, Suresh Menon, David T. Pride
Publikováno v:
Microbiology Spectrum, Vol 9, Iss 1 (2021)
ABSTRACT Tests to diagnose acute SARS-CoV-2 infection are at the center of controlling the COVID-19 pandemic. Rapid tests benefit from providing quick results but suffer from lower sensitivity, while PCR tests usually take longer to provide more reli
Externí odkaz:
https://doaj.org/article/e29da2aeb4db4fb4a1368f72ff86a13b
Publikováno v:
Journal of Clinical Virology Plus, Vol 1, Iss 1, Pp 100011- (2021)
There are numerous tests available for acute diagnosis of SARS-CoV-2, the virus that causes the disease COVID-19. These tests fall into two main groups: nucleic acid amplification tests (NAATs) and antigen-based assays. We evaluated the clinical perf
Externí odkaz:
https://doaj.org/article/2f68fb9acbf04f71afa79bb18529034e
Autor:
Bryan D. Bryson, Tracy R. Rosebrock, Fikadu G. Tafesse, Christopher Y. Itoh, Armel Nibasumba, Gregory H. Babunovic, Bjorn Corleis, Constance Martin, Caroline Keegan, Priscila Andrade, Susan Realegeno, Douglas Kwon, Robert L. Modlin, Sarah M. Fortune
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-11 (2019)
GM-CSF has been implicated in Mycobacterium tuberculosis (Mtb) host control. Here, the authors show that activation of GM-CSF discriminates Mtb-restrictive from -permissive macrophages while co-infection with HIV disrupts GM-CSF-mediated signaling, r
Externí odkaz:
https://doaj.org/article/7b1cd08cca8c4de48969bd62ffdea2d7
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
Carbapenem-resistant Klebsiella pneumoniae (CRKP) frequently causes hospital-acquired infections and is associated with high morbidity and mortality. CRKP can have multiple resistance mechanisms and only a few can be routinely detected by commercial
Externí odkaz:
https://doaj.org/article/b90ef9e24fe94513b357694af32326ec
Autor:
Susan Realegeno, Oladunni Adeyiga, Drew J. Winston, Omer E. Beaird, Omai B. Garner, Shangxin Yang
Publikováno v:
IDCases, Vol 26, Iss , Pp e01308- (2021)
A 44-year-old woman undergoing therapy for acute promyelocytic leukemia (APL) developed disseminated tuberculosis. Mycobacterium tuberculosis (TB) was isolated from the blood and sputum. Initial drug susceptibility testing (DST) of the blood isolate
Externí odkaz:
https://doaj.org/article/2b27cd73bc9545f28aa82b363cfe53b1
Publikováno v:
IDCases, Vol 20, Iss , Pp e00781- (2020)
We describe a case of carbapenem resistant E. coli isolated from urine in an 87-year-old woman with recurrent urinary tract infections. Using whole genome sequencing (WGS), we identified the carbapenem resistance mechanism to be a combination of ompC
Externí odkaz:
https://doaj.org/article/3a84d81c119c47b7a3fd4cd8fa54fba2
Autor:
Govind Prasad Sah, Grace Kovalick, Jessica Chopyk, Peiting Kuo, Lina Huang, Pooja Ghatbale, Promi Das, Susan Realegeno, Rob Knight, Jack A. Gilbert, David T. Pride
Publikováno v:
Microbiology spectrum, vol 11, iss 2
The exchange of microbes between humans and the built environment is a dynamic process that has significant impact on health. Most studies exploring the microbiome of the built environment have been predicated on improving our understanding of pathog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27765bbf389b9d50777ee1da14faacab
https://escholarship.org/uc/item/35b6665j
https://escholarship.org/uc/item/35b6665j
Autor:
Susan Realegeno, Utsav Pandey
Publikováno v:
Clinical Microbiology Newsletter. 44:83-90
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d386620445d45de69778c2c4cf62442
https://doi.org/10.1016/j.clinmicnews.2022.04.005
https://doi.org/10.1016/j.clinmicnews.2022.04.005
Autor:
Helena Escuin-Ordinas, Shuoran Li, Michael W. Xie, Lu Sun, Willy Hugo, Rong Rong Huang, Jing Jiao, Felipe Meira de-Faria, Susan Realegeno, Paige Krystofinski, Ariel Azhdam, Sara Marie D. Komenan, Mohammad Atefi, Begoña Comin-Anduix, Matteo Pellegrini, Alistair J. Cochran, Robert L. Modlin, Harvey R. Herschman, Roger S. Lo, William H. McBride, Tatiana Segura, Antoni Ribas
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-10 (2016)
BRAF inhibitors often show skin-hyperproliferative side effects in melanoma patients. Here, the authors demonstrate that BRAF inhibitors can be used to enhance skin wound healing through the MAPK- ERK pathway activation that positively regulates the
Externí odkaz:
https://doaj.org/article/4df7cfd06ae5433d88273671aa9365b6